BFM
STJ

Boothbay Fund Management’s St Jude Medical STJ Stock Holding History

Boothbay Fund Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,652
Closed -$213 – 1052
2016
Q4 		$213 Buy
+2,652
New +$210K 0.05% 569
2016
Q1 		– Sell
-6,537
Closed -$404K – 672
2015
Q4 		$404K Buy
+6,537
New +$412K 0.18% 166

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Boothbay Fund Management's STJ Position: Q1 2017 in Review

Boothbay Fund Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,652 shares — an estimated $213 sold.

Boothbay Fund Management first reported a position in STJ in Q4 2015 and held it in 2 quarters. The position peaked at $404K in Q4 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Boothbay Fund Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Boothbay Fund Management sold 2,652 St Jude Medical shares in Q1 2017, an estimated $213.
  • Boothbay Fund Management first reported a position in St Jude Medical in Q4 2015 and held it in 2 quarters.
  • Boothbay Fund Management's St Jude Medical position peaked at $404K in Q4 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Boothbay Fund Management's 13F filing for Q1 2017, filed 15 May 2017.